CADE Updates to Dow/DuPont and Monsanto/Bayer

Dow/DuPont Agrochemical giants Dow and DuPont are negotiating a remedy package with Brazilian CADE’s General Superintendence, a source familiar with the transaction told CTFN.featured

Kroton and Estácio Negotiate Remedies with CADE Tribunal

Brazil’s largest private education player Kroton Educacional and smaller rival Estácio Participações are proposing remedies aimed at easing concerns raised by CADE’s General Superintendencefeatured

Rivals Call for Conditional Approval of Dow/DuPont in Brazil

German chemical company BASF has asked Brazilian regulator CADE to impose remedies on the planned merger between US peers Dow and DuPont, CTFN has learned. In a regulatory filing published on Februaryfeatured

360b / Shutterstock.com

Brazilian Hospital Association Voices Concern over Praxair-Linde Merger

Associação dos Hospitais de Minas Gerais (AHMG), an association whose members are hospitals across Brazil’s southeastern state of Minas Gerais, is going to “defend its interests” in thefeatured

Update on Brazilian Reviews of Agrochem Deals

Brazilian regulator CADE is expected to prepare an opinion on ChemChina’s planned acquisition of Swiss agrochemical peer Syngenta by the second half of February, a source closefeatured

Linde Expected to Sell Brazilian Business for Praxair Merger

The planned merger between Connecticut-based industrial gas supplier Praxair and German peer Linde is raising significant concern in Brazil among a wide range of stakeholders, sourcesfeatured

CADE Launches In-Depth Probe of Dow/DuPont

Brazilian antitrust regulator CADE has declared the planned merger between Dow Chemical and DuPont “complex,” and launched an in-depth investigation aimed at further analyzingfeatured

Joy/Komatsu Moves forward in Australia and Brazil

The planned merger between underground mining equipment manufacturer Joy Global and Japanese player Komatsu has been unconditionally cleared in Brazil, while the Australian Competitionfeatured

OlegDoroshin / Shutterstock.com

Platform Specialty Calls for Conditions on Brazil’s Approval of Syngenta/ChemChina

Platform Specialty Products’ subsidiary Arysta LifeScience has raised concerns over the pending merger between Syngenta and ChemChina with Brazilian regulator CADE. In a filing on December 14, the company, which is bothfeatured

High Court Sanction of Odebrecht Settlement Could be Months Away

Brazilian corruption-tainted conglomerate Odebrecht is rumored to have signed a record-breaking $2.5 billion leniency agreement with public prosecutors. However, the agreement, which has not been officially confirmed by the company or thefeatured

X

Interested in a trial?

Simply fill out the form below and one of our representatives will be in touch.